448 related articles for article (PubMed ID: 16884303)
1. Structural insights into monoamine oxidase inhibitory potency and selectivity of 7-substituted coumarins from ligand- and target-based approaches.
Catto M; Nicolotti O; Leonetti F; Carotti A; Favia AD; Soto-Otero R; Méndez-Alvarez E; Carotti A
J Med Chem; 2006 Aug; 49(16):4912-25. PubMed ID: 16884303
[TBL] [Abstract][Full Text] [Related]
2. Discovery of a novel class of potent coumarin monoamine oxidase B inhibitors: development and biopharmacological profiling of 7-[(3-chlorobenzyl)oxy]-4-[(methylamino)methyl]-2H-chromen-2-one methanesulfonate (NW-1772) as a highly potent, selective, reversible, and orally active monoamine oxidase B inhibitor.
Pisani L; Muncipinto G; Miscioscia TF; Nicolotti O; Leonetti F; Catto M; Caccia C; Salvati P; Soto-Otero R; Mendez-Alvarez E; Passeleu C; Carotti A
J Med Chem; 2009 Nov; 52(21):6685-706. PubMed ID: 19810674
[TBL] [Abstract][Full Text] [Related]
3. New pyrrole inhibitors of monoamine oxidase: synthesis, biological evaluation, and structural determinants of MAO-A and MAO-B selectivity.
La Regina G; Silvestri R; Artico M; Lavecchia A; Novellino E; Befani O; Turini P; Agostinelli E
J Med Chem; 2007 Mar; 50(5):922-31. PubMed ID: 17256833
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and study of a series of 3-arylcoumarins as potent and selective monoamine oxidase B inhibitors.
Matos MJ; Terán C; Pérez-Castillo Y; Uriarte E; Santana L; Viña D
J Med Chem; 2011 Oct; 54(20):7127-37. PubMed ID: 21923181
[TBL] [Abstract][Full Text] [Related]
5. Sulfur-substituted alpha-alkyl phenethylamines as selective and reversible MAO-A inhibitors: biological activities, CoMFA analysis, and active site modeling.
Gallardo-Godoy A; Fierro A; McLean TH; Castillo M; Cassels BK; Reyes-Parada M; Nichols DE
J Med Chem; 2005 Apr; 48(7):2407-19. PubMed ID: 15801832
[TBL] [Abstract][Full Text] [Related]
6. Synthesis, molecular modeling, and selective inhibitory activity against human monoamine oxidases of 3-carboxamido-7-substituted coumarins.
Chimenti F; Secci D; Bolasco A; Chimenti P; Bizzarri B; Granese A; Carradori S; Yáñez M; Orallo F; Ortuso F; Alcaro S
J Med Chem; 2009 Apr; 52(7):1935-42. PubMed ID: 19267475
[TBL] [Abstract][Full Text] [Related]
7. Solid-phase synthesis and insights into structure-activity relationships of safinamide analogues as potent and selective inhibitors of type B monoamine oxidase.
Leonetti F; Capaldi C; Pisani L; Nicolotti O; Muncipinto G; Stefanachi A; Cellamare S; Caccia C; Carotti A
J Med Chem; 2007 Oct; 50(20):4909-16. PubMed ID: 17824599
[TBL] [Abstract][Full Text] [Related]
8. Impact of species-dependent differences on screening, design, and development of MAO B inhibitors.
Novaroli L; Daina A; Favre E; Bravo J; Carotti A; Leonetti F; Catto M; Carrupt PA; Reist M
J Med Chem; 2006 Oct; 49(21):6264-72. PubMed ID: 17034132
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and evaluation of 6-methyl-3-phenylcoumarins as potent and selective MAO-B inhibitors.
Matos MJ; Viña D; Picciau C; Orallo F; Santana L; Uriarte E
Bioorg Med Chem Lett; 2009 Sep; 19(17):5053-5. PubMed ID: 19628387
[TBL] [Abstract][Full Text] [Related]
10. Synthesis, human monoamine oxidase inhibitory activity and molecular docking studies of 3-heteroarylcoumarin derivatives.
Delogu G; Picciau C; Ferino G; Quezada E; Podda G; Uriarte E; Viña D
Eur J Med Chem; 2011 Apr; 46(4):1147-52. PubMed ID: 21316817
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and molecular modeling of some novel hexahydroindazole derivatives as potent monoamine oxidase inhibitors.
Gökhan-Kelekçi N; Simşek OO; Ercan A; Yelekçi K; Sahin ZS; Işik S; Uçar G; Bilgin AA
Bioorg Med Chem; 2009 Sep; 17(18):6761-72. PubMed ID: 19682910
[TBL] [Abstract][Full Text] [Related]
12. Lipophilicity plays a major role in modulating the inhibition of monoamine oxidase B by 7-substituted coumarins.
Carotti A; Altomare C; Catto M; Gnerre C; Summo L; De Marco A; Rose S; Jenner P; Testa B
Chem Biodivers; 2006 Feb; 3(2):134-49. PubMed ID: 17193252
[TBL] [Abstract][Full Text] [Related]
13. Synthesis, molecular modeling studies, and selective inhibitory activity against monoamine oxidase of 1-thiocarbamoyl-3,5-diaryl-4,5-dihydro-(1H)- pyrazole derivatives.
Chimenti F; Maccioni E; Secci D; Bolasco A; Chimenti P; Granese A; Befani O; Turini P; Alcaro S; Ortuso F; Cirilli R; La Torre F; Cardia MC; Distinto S
J Med Chem; 2005 Nov; 48(23):7113-22. PubMed ID: 16279769
[TBL] [Abstract][Full Text] [Related]
14. MAO inhibitory activity modulation: 3-Phenylcoumarins versus 3-benzoylcoumarins.
Matos MJ; Vazquez-Rodriguez S; Uriarte E; Santana L; Viña D
Bioorg Med Chem Lett; 2011 Jul; 21(14):4224-7. PubMed ID: 21684743
[TBL] [Abstract][Full Text] [Related]
15. Selective inhibitory activity against MAO and molecular modeling studies of 2-thiazolylhydrazone derivatives.
Chimenti F; Maccioni E; Secci D; Bolasco A; Chimenti P; Granese A; Befani O; Turini P; Alcaro S; Ortuso F; Cardia MC; Distinto S
J Med Chem; 2007 Feb; 50(4):707-12. PubMed ID: 17253676
[TBL] [Abstract][Full Text] [Related]
16. Synthesis of new 7-oxycoumarin derivatives as potent and selective monoamine oxidase A inhibitors.
Abdelhafez OM; Amin KM; Ali HI; Abdalla MM; Batran RZ
J Med Chem; 2012 Dec; 55(23):10424-36. PubMed ID: 23153282
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of monoamine oxidases by coumarin-3-acyl derivatives: biological activity and computational study.
Chimenti F; Secci D; Bolasco A; Chimenti P; Granese A; Befani O; Turini P; Alcaro S; Ortuso F
Bioorg Med Chem Lett; 2004 Jul; 14(14):3697-703. PubMed ID: 15203146
[TBL] [Abstract][Full Text] [Related]
18. A QSAR model for in silico screening of MAO-A inhibitors. Prediction, synthesis, and biological assay of novel coumarins.
Santana L; Uriarte E; González-Díaz H; Zagotto G; Soto-Otero R; Méndez-Alvarez E
J Med Chem; 2006 Feb; 49(3):1149-56. PubMed ID: 16451079
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and monoamine oxidase inhibitory activity of new pyridazine-, pyrimidine- and 1,2,4-triazine-containing tricyclic derivatives.
Carotti A; Catto M; Leonetti F; Campagna F; Soto-Otero R; Méndez-Alvarez E; Thull U; Testa B; Altomare C
J Med Chem; 2007 Nov; 50(22):5364-71. PubMed ID: 17910428
[TBL] [Abstract][Full Text] [Related]
20. Chromone, a privileged scaffold for the development of monoamine oxidase inhibitors.
Gaspar A; Silva T; Yáñez M; Vina D; Orallo F; Ortuso F; Uriarte E; Alcaro S; Borges F
J Med Chem; 2011 Jul; 54(14):5165-73. PubMed ID: 21696156
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
